|
The muscular dystrophies (MDs) are a group of inherited diseases causing progressive muscle wasting and weakness. Biotrofix is highly experienced with mouse models of MD (including Duchenne and Miyoshi dystrophies), including studies of drug and stem cell administration in these models. Endpoints of these studies are histological and functional (muscle strength). |
Biotrofix is a premier preclinical contract research organization specializing in animal models of CNS, cardiac and vascular disease. With years of experience, both academic, commercial, clients throughout the biotech and pharmaceutical industries, Biotrofix delivers industry-leading preclinical CRO services, including rodent models of acute stroke and stroke recovery, preclinical CRO services for Alzheimer's Disease, transgenic animal models for ALS, as well as CRO services for brain injury, preclinical CRO services for spinal cord injury and related cardiac drug discovery and development. |